CMLT20100 / S1823 / Chunkit Fung
Research Question:
Studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the
chance of cancer returning in patients with germ cell cancers.
Basic Study Information
Purpose:
This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can
predict the chance of cancer returning in patients with germ cell cancers. Studying
samples of blood from patients with germ cell cancers in the laboratory may help doctors
predict how likely the cancer will come back.
Location: University of Rochester Medical Center
Study Reference #: CMLT20100
Lead Researcher (Principal Investigator)
Lead Researcher:
Chunkit Fung
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search